BioDelivery Sciences International, Inc. appointed James Vollins as General Counsel and member of its Executive Leadership Team effective November 5, 2018. Mr. Vollins will also serve as the Company's Chief Compliance Officer and Corporate Secretary. Jim brings over 25 years of extensive legal experience including serving as general counsel and assistant general counsel for several successful healthcare companies and as senior external counsel covering a variety of legal matters.

Mr. Vollins is well versed in the fields of securities law, corporate governance and regulatory compliance relating to the commercialization and reimbursement of pharmaceutical products in the U.S. The company also announced the retirement of Ernest R. DePaolantonio, Chief Financial Officer and Corporate Secretary, which is expected to occur by mid-2019. The company announced the enhanced title of Scott Plesha to President and Chief Commercial Officer of the Company. This change recognizes the broader role and contributions Scott has undertaken in leading the very successful growth of BELBUCA® over the last eighteen months, and the important role the commercial organization will continue to play in the future of BDSI.